Join
Live feed
·
INSIDERFilingvia Quantisnow
TCR2 Therapeutics Inc. logo

SEC Form 4: Olagunju Peter sold $3,531 worth of shares (2,618 units at $1.35) as part of a pre-agreed trading plan, decreasing direct ownership by 8% to 31,710 units (tax liability)

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track TCRR (TCR2 Therapeutics Inc.) and more on Quantisnow.